Cell. 2009 Dec 11;139(6):1032-7. doi: 10.1016/j.cell.2009.11.039.

iPS cells: mapping the policy issues.

Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, Heine H, Isasi R, Kato K, Lovell-Badge R, McNagny K, Pei D, Rossant J, Surani A, Taylor PL, Ogbogu U, Caulfield T.

Source

Health Law Institute, University of Alberta, Edmonton, Alberta T6G 2H5, Canada.

Abstract

Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.

PMID:: 20005794; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Review ES and iPS cell research for cardiovascular regeneration. [Exp Cell Res. 2010]
Review ES and iPS cell research for cardiovascular regeneration.
Yamashita JK. Exp Cell Res. 2010 Oct 1; 316(16):2555-9. Epub 2010 Apr 10.
Induced pluripotent stem cell technology for the study of human disease. [Nat Methods. 2010]
Induced pluripotent stem cell technology for the study of human disease.
Lee G, Studer L. Nat Methods. 2010 Jan; 7(1):25-7.
iPS cells: potent stuff. [Nat Methods. 2010]
iPS cells: potent stuff.
Baker M. Nat Methods. 2010 Jan; 7(1):17-9.
Review ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective. [Pediatr Surg Int. 2010]
Review ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.
Pozzobon M, Ghionzoli M, De Coppi P. Pediatr Surg Int. 2010 Jan; 26(1):3-10. Epub 2009 Sep 1.
Will iPS cells enhance therapeutic applicability of cord blood cells and banking? [Cell Stem Cell. 2010]
Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
Broxmeyer HE. Cell Stem Cell. 2010 Jan 8; 6(1):21-4.

See reviews... See all...

Cited by 7 PubMed Central articles

Cell therapy: cGMP facilities and manufacturing. [Muscles Ligaments Tendons J. 2...]
Cell therapy: cGMP facilities and manufacturing.
Giancola R, Bonfini T, Iacone A. Muscles Ligaments Tendons J. 2012 Jul; 2(3):243-7. Epub 2012 Oct 16.
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. [Stem Cells Transl Med. 2012]
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.
Lowenthal J, Lipnick S, Rao M, Hull SC. Stem Cells Transl Med. 2012 May; 1(5):409-21. Epub 2012 May 8.
Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions. [PLoS One. 2012]
Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions.
Qu X, Liu T, Song K, Li X, Ge D. PLoS One. 2012; 7(10):e48161. Epub 2012 Oct 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

iPS cells: mapping the policy issues.
iPS cells: mapping the policy issues.
Cell. 2009 Dec 11 ;139(6):1032-7. doi: 10.1016/j.cell.2009.11.039.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: